Facts and Figures

Facts and Figures

MEDICLIN at a glance: Management Board, company profile, key data on business development and other important key data

Key data and key figures

Please inform yourself about the share development and the business development.

Company key data

Company and registered office

MEDICLIN Aktiengesellschaft Okenstraße 27, 77652 Offenburg

Management Board

Volker Hippler (CEO), Tino Fritz (CFO)

Company profile

MEDICLIN offers professionel medical services in the fields of acute care and rehabilitation (post-acute care) as well as inpatient nursing care services throughout Germany.

Number of facilities

36 medical facilities and seven nursing care facilities and ten medical care centers in eleven federal states in Germany

Number of beds / care places

rund 8.350 / about 400

Staff

More than 10,000

ISIN; WKN

DE0006595101; 659510

Ticker symbol

MED

Trading segment

Prime Standard, Pharma & Health Care

Indices

Prima All Share, CDAX

Number of shares

47,500,000 no-Par bearer shares

Registered capital

47,5000,000 Euro

Shareholder structure

Asklepios Kliniken GmbH & Co. KGaA, ERGO Group AG, Free Float

52,73% 35,00%, 12,27%

As at November 2019


Key data of business development

in millions of €

2018

2017

Sales

645,1

609,1

EBITDA

37,3

27,0

EBIT

15,1

6,6

EBITDA margin

5,8%

4,4%

EBIT margin

2,3%

1,1%

Total consolidated result

7,8

4,0

Eearings per share in €

0,16

0,08

Diviend per share in €

0,05

0,05

Gross capital expenditure

49,3

46,8

Cash flow from operating activities

29,7

20,1

Number of cases (inpatient)

122.954

122.259

Number of beds as of 31.12.

8.324

8.267

Occupancy rate

89,1%

88,2%

Number of full-time employees (annual average)

7.116

6.964

Number of shares in millions

47,5

47,5

Due to arithmetical reasons, calculation differences of +/- one unit (€,%,etc,) may occur. Percentage rates have been determined on the basis of € values.

Your contacts

Gabriele Eberle

Gabriele Eberle

Chief of communications, Pressspeaker

Alexandra Mühr

Alexandra Mühr

Investor Relations